MedPath

A study on quality of life in Prosthakola veekkam (Benign prostatic hyperplasia) patients taking siddha treatment

Not Applicable
Conditions
Health Condition 1: N401- Benign prostatic hyperplasia withlower urinary tract symptoms
Registration Number
CTRI/2023/02/049626
Lead Sponsor
ational Institute of Siddha
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.K/C/O Benign Prostatic Hyperplasia and newly diagnosed BPH

patients

2.Patients who would take 48 days of Siddha treatment for Prosthakola veekkam (BPH) at Ayothidoss Pandithar hospital NIS

3.Patients who are willing to give informed consent

Exclusion Criteria

1. Age below 50 and above 80 years

2.K/C/O Prostatic malignancy

3.K/C/O Urinary bladder calculus

4.Patients with prior history of prostatic/urethral surgery

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Difference in BPH Specific Quality of life scale will be assessed form baseline <br/ ><br>through endpoint with Benign Prostatic hyperplasia targeted siddha treatmentTimepoint: 4 months-Data collection <br/ ><br>2 months- Data analysis and outcome
Secondary Outcome Measures
NameTimeMethod
ILTimepoint: NI
© Copyright 2025. All Rights Reserved by MedPath